- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06092970
An Evaluation of Patient Reported Outcomes and Clinical Outcomes
April 12, 2024 updated by: Renibus Therapeutics, Inc.
Clinical Protocol REN-007E - Extension Study: An Evaluation of Patient Reported Outcomes and Clinical Outcomes Through 12 Months Post-Cardiac Surgery in Patients Enrolled in Study REN-007
This extension study is being conducted to assess the following objectives through 12 months post-cardiac surgery:
- Patient reported outcomes (PRO), using the EQ-5D questionnaire
- Clinical outcomes
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
400
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Andre Lamy, MD
Study Contact Backup
- Name: Jennifer Paleveda
- Phone Number: 813-760-3975
- Email: jpaleveda@renibus.com
Study Locations
-
-
New Brunswick
-
Saint John, New Brunswick, Canada, E2L 4L2
- Recruiting
- Research Site
-
-
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20010
- Recruiting
- Research Site
-
-
Indiana
-
Fort Wayne, Indiana, United States, 46804
- Recruiting
- Research Site
-
Indianapolis, Indiana, United States, 46202
- Recruiting
- Research Site
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Recruiting
- Research Site
-
-
Michigan
-
Lansing, Michigan, United States, 48879
- Recruiting
- Research Site
-
Midland, Michigan, United States, 48670
- Recruiting
- Research Site
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Recruiting
- Research Site
-
-
New York
-
Flushing, New York, United States, 11355
- Recruiting
- New York Presbyterian-Queens
-
-
North Carolina
-
Raleigh, North Carolina, United States, 27610
- Recruiting
- Research Site
-
-
Ohio
-
Cleveland, Ohio, United States, 44106
- Recruiting
- Research Site
-
Toledo, Ohio, United States, 43606
- Recruiting
- Research Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
All subjects who complete the Phase 3 REN-007 study are eligible to participate in the Extension Study.
Description
Inclusion Criteria:
- Subjects must have completed the REN-007 study to be eligible to participate in the Extension Study.
Exclusion Criteria:
- Subjects who did not complete the REN-007 study are not eligible to participate in the Extension Study.
- Female subjects who become pregnant during the REN-007 study are not eligible to participate in the Extension Study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
RBT-1
Patients undergoing CABG, valve, or combined CABG/valve surgery
|
Intravenous administration
|
Placebo
Patients undergoing CABG, valve, or combined CABG/valve surgery
|
Intravenous administration
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation
Time Frame: 12 Months Post-Cardiac Surgery
|
To evaluate patient reported outcomes (PRO) using the EQ-5D questionnaire
|
12 Months Post-Cardiac Surgery
|
Evaluation
Time Frame: 12 Months Post-Cardiac Surgery
|
The number of subjects with the following clinical outcomes will be reported Clinical Outcomes:
|
12 Months Post-Cardiac Surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 16, 2023
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2026
Study Registration Dates
First Submitted
October 3, 2023
First Submitted That Met QC Criteria
October 16, 2023
First Posted (Actual)
October 23, 2023
Study Record Updates
Last Update Posted (Estimated)
April 15, 2024
Last Update Submitted That Met QC Criteria
April 12, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REN-007E
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-Operative Complications in Cardiac Surgery
-
Renibus Therapeutics, Inc.RecruitingPost-Operative Complications in Cardiac SurgeryUnited States, Canada
-
Hospices Civils de LyonRecruitingPost-operative Complications After Colorectal Surgery | Post-operative Complications After Gastric Surgery | Post-operative Complications After Bariatric SurgeryFrance
-
Hospices Civils de LyonCompletedPost Operative Care After Cardiac Surgery With Cardio Pulmonary BypassFrance
-
Gyeongsang National University HospitalTerminatedCardiac Complications of Care (& [Post Operative])Korea, Republic of
-
University of LiegeRecruiting
-
Superior UniversityActive, not recruitingSurgery-ComplicationsPakistan
-
University Hospital, Clermont-FerrandUnknownCardiac Surgery | Post-operative PainFrance
-
University of British ColumbiaProvidence Health & Services; Canadian Anesthesiologists' SocietyRecruitingCardiac Disease | Post-operative Pain | Post-cardiac SurgeryCanada
-
Rambam Health Care CampusCompleted
-
Multan Medical And Dental CollegeCompleted
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
ItalfarmacoCompletedBecker Muscular DystrophyNetherlands, Italy
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States